STRIDES PHARMA SCIENCE LTD Q4 RESULTS
Strides Pharma Science Q3 net declines 69% to Rs 92 crore
The consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.
Our drug Ranitidine is safe: Strides Pharma
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model Lis...
Bayer CropScience Q2 profit rises slightly to Rs 170 crore
Total income rose to Rs 1,356.5 crore against Rs 1,249.1 crore.
Strides Pharma relaunches Ranitidine tablets in US
The company had suspended sales of its generic Ranitidine tablets after the USFDA found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA. Strides said now the drug meets the limits prescribed by the US drug regulator.
Strides Pharma shares plunge 8% as company suspends sales of ranitidine tablets in US
On the National Stock Exchange, it cracked 7.94 per cent to close at Rs 302.60.
Stocks in the news: Gati, Bharti Airtel, Alembic Pharma, Aster DM and DHFL
GMR Infra has raised Rs 2,000 crore debt through nonconvertible debentures from Tata Sons.
What to watch out for in Sun Pharma’s Q4 results
The drug major is expected to post a 12.3 per cent increase in net sales to Rs 7,537 crore.
Why S Naren is betting on small and midcap stocks in power and infra
Smallcaps have better absolute return potential in long term over midcaps & largecaps.
Sun Pharma drops post Q4 nos; brokerages mixed
Analysts in an ET NOW poll had projected the profit figure to be at Rs 976 crore.
20 firms turned around in Q2! Are they compelling ‘buy’ ideas now?
Seventeen of these 20 stocks posted up to 51 per cent YoY rise in net sales for the quarter.
Cipla Q4 profit beats estimates; top highlights
In Q4, North America delivered strong growth of 41 per cent YoY and 38 per cent QoQ.
Sun in transition, stock to stay in range
For now, long-term investors will have to wait and watch.
Midcaps will outperform largecaps over 2-3 years: Kashyap Pujara, Axis Capital
It is going to be a U-shaped recovery for the midcaps, said Kashyap Pujara.
Buy Sun Pharmaceutical Industries, target Rs 520: CLSA
Sun Pharma is a largecap company, operating in pharmaceuticals and health care sector.
Biocon number six in top 10 Global Biotech Employers ranking for 2019
Biocon continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list, since its debut in 2012.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service